Yetong Feng
- Molecular Biology
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 5%
- Immunology
- Epidemiology
- Topics
- Ferroptosis and cancer prognosis (7 papers)Mesenchymal stem cell research (5 papers)RNA modifications and cancer (4 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEScientific Reports
- Partner nations
- ChinaSwedenUnited States
In The Last Decade
Yetong Feng
26 papers receiving 960 citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Molecular Biology 545
- Pulmonary and Respiratory Medicine 514
- Cancer Research 392
- Immunology 82
- Epidemiology 74
Countries citing papers authored by Yetong Feng
This map shows the geographic impact of Yetong Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yetong Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yetong Feng more than expected).
Fields of papers citing papers by Yetong Feng
This network shows the impact of papers produced by Yetong Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yetong Feng. The network helps show where Yetong Feng may publish in the future.
Co-authorship network of co-authors of Yetong Feng
This figure shows the co-authorship network connecting the top 25 collaborators of Yetong Feng. A scholar is included among the top collaborators of Yetong Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yetong Feng. Yetong Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 12 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 4 | |
| 9 | 0 | |
| 10 | 1 | |
| 11 | 39 | |
| 12 | Ferrostatin-1 alleviates lipopolysaccharide-induced acute lung injury via inhibiting ferroptosisbreakdown → | 496 |
| 13 | 6 | |
| 14 | 20 | |
| 15 | 5 | |
| 16 | 9 | |
| 17 | 44 | |
| 18 | 28 | |
| 19 | 11 | |
| 20 | 29 |
About Yetong Feng
Yetong Feng is a scholar working on Hepatology, Developmental Neuroscience and Genetics, having authored 28 papers that have together received 964 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (7 papers), Mesenchymal stem cell research (5 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (392 citations), Pulmonary and Respiratory Medicine (514 citations) and Molecular Biology (545 citations). Yetong Feng has collaborated with scholars based in China, Sweden and United States. Frequent co-authors include Lei Zhao, Pengfei Liu, Guangsuo Wang, Yalan Li, Xin Chen, Shiyuan Xu, Hanwei Li, Yulai Zhou, Di Wu and Pengfei Liu. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.